SCHEMBL22459323

SCHEMBL22459323

C=C(COC)C(=O)OCCOc1ccc(-c2ccc(O)c(F)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 2/20 0.43
▸ RARA P10276 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ MCL1 Q07820 1/20 0.37
▸ CYP17A1 P05093 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP19A1 P11511 2/20 0.37
▸ CYP11B1 P15538 2/20 0.37
▸ CYP11B2 P19099 2/20 0.37
▸ ESR1 P03372 3/20 0.35
▸ ESR2 Q92731 3/20 0.35
▸ HSD17B1 P14061 2/20 0.35
▸ HSD17B2 P37059 2/20 0.35
▸ POLB P06746 1/20 0.34
▸ APEX1 P27695 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ACACB O00763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21422426 0.89 RARB (0.43) RARBRARACYP17A1MAPT
SCHEMBL22459266 0.89 RARB (0.43) RARBRARAPOLBAPEX1HTT
SCHEMBL22459796 0.89 RARB (0.43) RARBRARAPOLBAPEX1HTT
SCHEMBL22459248 0.87 POLB (0.43) RARBLMNACYP3A4POLBAPEX1
SCHEMBL22459449 0.87 POLB (0.43) RARBLMNACYP3A4POLBAPEX1
SCHEMBL22459353 0.87 POLB (0.43) RARBLMNACYP3A4POLBAPEX1
SCHEMBL22459366 0.85 POLB (0.41) RARBRARAPOLBAPEX1HTT
SCHEMBL22459241 0.82 PDE4A (0.39) RARBRARALMNAPOLBAPEX1
SCHEMBL22459326 0.82 POLB (0.39) RARBLMNACYP3A4POLBAPEX1
SCHEMBL22459422 0.82 POLB (0.39) RARBLMNACYP3A4POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 RARB 3668/4885RARA 3532/4885KDM4E 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback